Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity
Condition(s):Chronic Allograft Injury; Calcineurin Inhibitor ToxicityLast Updated:October 16, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Chronic Allograft Injury; Calcineurin Inhibitor ToxicityLast Updated:October 16, 2018Terminated
Condition(s):Delayed Graft FunctionLast Updated:April 26, 2019Terminated
Condition(s):Highly-sensitized Kidney Transplant RecipientsLast Updated:December 7, 2017Completed
Condition(s):High Model for End-Stage Liver Disease (MELD) ScoreLast Updated:October 21, 2019Withdrawn
Condition(s):Idiopathic Subglottic Tracheal StenosisLast Updated:December 21, 2023Active, not recruiting
Condition(s):Uterine SarcomaLast Updated:December 1, 2023Available
Condition(s):Gastrointestinal Stromal TumorLast Updated:June 18, 2023Temporarily not available
Condition(s):Immunosuppression; Renal FailureLast Updated:January 29, 2021Completed
Condition(s):Kidney FailureLast Updated:May 24, 2023Terminated
Condition(s):Orthotopic Liver TransplantLast Updated:August 10, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.